<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7102556\results\search\disease\results.xml">
  <result pre="S1286-4579(20)30025-3 doi: 10.1016/j.micinf.2020.01.003 : Article Measures for diagnosing and treating" exact="infections" post="by a novel coronavirus responsible for a pneumonia outbreak"/>
  <result pre="and treating infections by a novel coronavirus responsible for a" exact="pneumonia" post="outbreak originating in Wuhan, China YuFeiaDuLanyingbOjciusDavid M.cPanChungenchungenp@163.comdâˆ—JiangShiboshibojiang@fudan.edu.cnbeâˆ—âˆ—[a], [b], [c],"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="Abstract On 10 January 2020, a new coronavirus causing a" exact="pneumonia" post="outbreak in Wuhan City in central China was denoted"/>
  <result pre="beta, delta and gamma coronavirus. The emerging CoVs, including severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome"/>
  <result pre="delta and gamma coronavirus. The emerging CoVs, including severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus"/>
  <result pre="and gamma coronavirus. The emerging CoVs, including severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV),"/>
  <result pre="including severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV), both belonging to beta coronavirus, have"/>
  <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV), both belonging to beta coronavirus, have caused"/>
  <result pre="both belonging to beta coronavirus, have caused recent pandemics of" exact="respiratory" post="infectious diseases with high mortality. At the end of"/>
  <result pre="belonging to beta coronavirus, have caused recent pandemics of respiratory" exact="infectious diseases" post="with high mortality. At the end of December 2019,"/>
  <result pre="2019, the Wuhan Municipal Health Commission reported the outbreak of" exact="viral pneumonia" post="caused by an unknown pathogen in Wuhan, China [1]."/>
  <result pre="the Wuhan Municipal Health Commission reported the outbreak of viral" exact="pneumonia" post="caused by an unknown pathogen in Wuhan, China [1]."/>
  <result pre="advances made in technologies for rapid diagnosis and identification of" exact="respiratory" post="infections caused by coronavirus, as well as strategies for"/>
  <result pre="made in technologies for rapid diagnosis and identification of respiratory" exact="infections" post="caused by coronavirus, as well as strategies for research"/>
  <result pre="emerging coronavirus Identification of pathogens mainly includes virus isolation and" exact="viral" post="nucleic acid detection. According to the traditional Kochâ€™s postulates,"/>
  <result pre="the â€œgold standardâ€� for virus diagnosis in the laboratory. First," exact="viral" post="culture is a prerequisite for diagnosing viral infections. A"/>
  <result pre="the laboratory. First, viral culture is a prerequisite for diagnosing" exact="viral" post="infections. A variety of specimens (such as swabs, nasal"/>
  <result pre="manner, which gives a higher rate of positive detection of" exact="lower" post="respiratory tract specimens. Then, immunological methods â€&quot; including immunofluorescence"/>
  <result pre="which gives a higher rate of positive detection of lower" exact="respiratory" post="tract specimens. Then, immunological methods â€&quot; including immunofluorescence assay,"/>
  <result pre="corresponding antibody, are easy to operate rapidly but have a" exact="lower" post="sensitivity and specificity [3,4]. In addition, other immunological methods,"/>
  <result pre="the coronavirus spike protein [5,6]. In the case of 2019-nCoV," exact="viral" post="research institutions can conduct preliminary identification of the virus"/>
  <result pre="the virus through the classical Kochâ€™s Postulates or observing its" exact="morphology" post="through an electron microscopy [7]. Serology could also be"/>
  <result pre="[9]]. All the examples above are traditional virus detection methods." exact="Viral" post="nucleic acids can also be used for early diagnosis."/>
  <result pre="pGEM-MERSS2 as templates, respectively [12]. Also, samples collected from the" exact="upper" post="respiratory tract (oropharyngeal and nasopharyngeal) and lower respiratory tract"/>
  <result pre="as templates, respectively [12]. Also, samples collected from the upper" exact="respiratory" post="tract (oropharyngeal and nasopharyngeal) and lower respiratory tract (endotracheal"/>
  <result pre="collected from the upper respiratory tract (oropharyngeal and nasopharyngeal) and" exact="lower" post="respiratory tract (endotracheal aspirate, expectorated sputum, or bronchoalveolar lavage)"/>
  <result pre="from the upper respiratory tract (oropharyngeal and nasopharyngeal) and lower" exact="respiratory" post="tract (endotracheal aspirate, expectorated sputum, or bronchoalveolar lavage) of"/>
  <result pre="The color change of AgNPs can distinguish between MERS-CoV, Mycobacterium" exact="tuberculosis" post="(MTB), and human papillomavirus (HPV). 2 Research and development"/>
  <result pre="protein has been evaluated in different types of vaccines against" exact="infection" post="by CoVs [29]. Apart from the inactive whole virus"/>
  <result pre="These include a virus-like particle which incorporated S protein into" exact="hepatitis" post="virus or influenza virus protein [32,33]; virus vectors, such"/>
  <result pre="or influenza virus protein [32,33]; virus vectors, such as modified" exact="vaccinia" post="virus Ankara (MVA) or Adenovirus carrying S protein [34,35];"/>
  <result pre="and assessed the possibility of developing universal vaccines against coronavirus" exact="infections" post="[40]. Most CoVs share a similar viral structure, similar"/>
  <result pre="vaccines against coronavirus infections [40]. Most CoVs share a similar" exact="viral" post="structure, similar infection pathway, and a similar structure of"/>
  <result pre="infections [40]. Most CoVs share a similar viral structure, similar" exact="infection" post="pathway, and a similar structure of the S proteins"/>
  <result pre="implying that neutralizing antibodies that were so effective against SARS-CoV" exact="infection" post="may fail to recognize the 2019-nCoV, and that multiple"/>
  <result pre="transmission. Fig.Â 1 Comparison of S protein sequences of coronaviruses." exact="Multiple" post="alignment of full amino acid sequences of S protein"/>
  <result pre="cores, which are critical regions responsible for the formation of" exact="stable" post="six-helical bundles between HR1 and HR2. However, several bottlenecks"/>
  <result pre="or non-neutralization antibody epitopes in vaccines that may elicit antibody-mediated" exact="disease" post="enhancement (ADE) [46]. Third, DNA vaccines may recombine with"/>
  <result pre="vaccine could induce neutralizing antibody responses and protection against SARS-CoV" exact="infection" post="in the immunized animals, while it did not elicit"/>
  <result pre="no specific antiviral therapy has been approved for treatment of" exact="infection" post="by human CoVs. As development of vaccines and compounds"/>
  <result pre="development of vaccines and compounds for prevention and treatment of" exact="infection" post="have been brought to priority status by WHO and"/>
  <result pre="mediated virus-cell membrane fusion, and some of them interfere with" exact="viral" post="replication [57]. 3.1 CoV fusion/entry inhibitors Based on the"/>
  <result pre="bundle (6-HB), blocking S protein-mediated membrane fusion and inhibiting SARS-CoV" exact="infection" post="[59]. When MERS-CoV was circulating in human populations in"/>
  <result pre="the virus HR2 region as well and effectively inhibited MERS-CoV" exact="infection" post="[60]. The further modified version of HR2P, HR2P-M2, presented"/>
  <result pre="pan-CoV fusion inhibitor, EK1, was generated. It could form a" exact="stable" post="six-helix bundle (6-HB) structure with HR1s and showed significantly"/>
  <result pre="been successfully discovered for treatment of SARS-CoV [67] and MERS-CoV" exact="infection" post="[45,68,69]. These antibodies have all been described favorably in"/>
  <result pre="out from non-immune humans [72,73]. Antibodies effective at inhibiting SARS-CoV" exact="infection" post="should also have the potential for treatment of 2019-nCoV"/>
  <result pre="used in patients, numerous drugs developed for the treatment of" exact="infection" post="with CoVs were thoroughly discussed in the literature [57]."/>
  <result pre="a highly diverse genome. Recombination also easily takes place between" exact="viral" post="genomes [80], and these gene level changes may result"/>
  <result pre="immunofluorescent and neutralizing antibody testsJÂ Infect67201313014023583636 4AburizaizaA.S.MattesF.M.AzharE.I.HassanA.M.MemishZ.A.MuthD.Investigation of anti-middle East" exact="respiratory" post="syndrome antibodies in blood donors and slaughterhouse workers in"/>
  <result pre="and neutralizing antibody testsJÂ Infect67201313014023583636 4AburizaizaA.S.MattesF.M.AzharE.I.HassanA.M.MemishZ.A.MuthD.Investigation of anti-middle East respiratory" exact="syndrome" post="antibodies in blood donors and slaughterhouse workers in Jeddah"/>
  <result pre="pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for" exact="viral" post="entry inhibitors against the novel human coronavirus MERS-CoVVirol J10201326623978242"/>
  <result pre="inhibitors against the novel human coronavirus MERS-CoVVirol J10201326623978242 7LuH.StrattonC.W.TangY.W.Outbreak of" exact="pneumonia" post="of unknown etiology in Wuhan China: the mystery and"/>
  <result pre="8WHO: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2. 9WHO: https://www.who.int/docs/default-source/coronaviruse/20200114-interim-laboratory-guidance-version.pdf?sfvrsn=6967c39b_4&amp;amp;download=true. 10https://www.gisaid.org/. 11http://virological.org/t/initial-assessment-of-the-ability-of-published-coronavirus-primers-sets-to-detect-the-wuhan-coronavirus/321. 12NohJ.Y.YoonS.W.KimD.J.LeeM.S.KimJ.H.NaW.Simultaneous detection of severe" exact="acute" post="respiratory syndrome, Middle East respiratory syndrome, and related bat"/>
  <result pre="https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2. 9WHO: https://www.who.int/docs/default-source/coronaviruse/20200114-interim-laboratory-guidance-version.pdf?sfvrsn=6967c39b_4&amp;amp;download=true. 10https://www.gisaid.org/. 11http://virological.org/t/initial-assessment-of-the-ability-of-published-coronavirus-primers-sets-to-detect-the-wuhan-coronavirus/321. 12NohJ.Y.YoonS.W.KimD.J.LeeM.S.KimJ.H.NaW.Simultaneous detection of severe acute" exact="respiratory" post="syndrome, Middle East respiratory syndrome, and related bat coronaviruses"/>
  <result pre="11http://virological.org/t/initial-assessment-of-the-ability-of-published-coronavirus-primers-sets-to-detect-the-wuhan-coronavirus/321. 12NohJ.Y.YoonS.W.KimD.J.LeeM.S.KimJ.H.NaW.Simultaneous detection of severe acute respiratory syndrome, Middle East" exact="respiratory" post="syndrome, and related bat coronaviruses by real-time reverse transcription"/>
  <result pre="isothermal PCR assays for the detection of the Middle East" exact="respiratory" post="syndrome-coronavirusJÂ Mol Diagn19201781782728807812 14LuX.WhitakerB.SakthivelS.K.KamiliS.RoseL.E.LoweL.Real-time reverse transcription-PCR assay panel for"/>
  <result pre="Mol Diagn19201781782728807812 14LuX.WhitakerB.SakthivelS.K.KamiliS.RoseL.E.LoweL.Real-time reverse transcription-PCR assay panel for Middle East" exact="respiratory" post="syndrome coronavirusJÂ Clin Microbiol522014677524153118 15CormanV.M.EckerleI.BleickerT.ZakiA.LandtO.Eschbach-BludauM.Detection of a novel human"/>
  <result pre="Diagn19201781782728807812 14LuX.WhitakerB.SakthivelS.K.KamiliS.RoseL.E.LoweL.Real-time reverse transcription-PCR assay panel for Middle East respiratory" exact="syndrome" post="coronavirusJÂ Clin Microbiol522014677524153118 15CormanV.M.EckerleI.BleickerT.ZakiA.LandtO.Eschbach-BludauM.Detection of a novel human coronavirus"/>
  <result pre="Red Crescent Med J182016e2387428191331 17WHO: https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf?sfvrsn=d381fc88_2. 18ShiratoK.YanoT.SenbaS.AkachiS.KobayashiT.NishinakaT.Detection of Middle East" exact="respiratory" post="syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)Virol"/>
  <result pre="Crescent Med J182016e2387428191331 17WHO: https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf?sfvrsn=d381fc88_2. 18ShiratoK.YanoT.SenbaS.AkachiS.KobayashiT.NishinakaT.Detection of Middle East respiratory" exact="syndrome" post="coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)Virol J11201413925103205"/>
  <result pre="recombinase polymerase amplification assay for the detection of middle East" exact="respiratory" post="syndrome coronavirusPLoS Curr52013 22XiuL.ZhangC.WuZ.PengJ.Establishment and application of a universal"/>
  <result pre="polymerase amplification assay for the detection of middle East respiratory" exact="syndrome" post="coronavirusPLoS Curr52013 22XiuL.ZhangC.WuZ.PengJ.Establishment and application of a universal coronavirus"/>
  <result pre="23KooB.HongK.H.JinC.E.KimJ.Y.KimS.H.ShinY.Arch-shaped multiple-target sensing for rapid diagnosis and identification of emerging" exact="infectious" post="pathogensBiosens Bioelectron1192018798530103157 24TeengamP.SiangprohW.TuantranontA.VilaivanT.ChailapakulO.HenryC.S.Multiplex paper-based colorimetric DNA sensor using Pyrrolidinyl"/>
  <result pre="N-terminal heptad repeat domain of HIV-1 gp41 is critical for" exact="viral" post="fusion and entryPloS One72012e4487422970321 29ZhouY.YangY.HuangJ.JiangS.DuL.Advances in MERS-CoV vaccines and"/>
  <result pre="based on the receptor-binding domainViruses112019E6030646569 30AgrawalA.S.TaoX.AlgaissiA.GarronT.NarayananK.PengB.H.Immunization with inactivated Middle East" exact="Respiratory" post="Syndrome coronavirus vaccine leads to lung immunopathology on challenge"/>
  <result pre="on the receptor-binding domainViruses112019E6030646569 30AgrawalA.S.TaoX.AlgaissiA.GarronT.NarayananK.PengB.H.Immunization with inactivated Middle East Respiratory" exact="Syndrome" post="coronavirus vaccine leads to lung immunopathology on challenge with"/>
  <result pre="challenge with live virusHum Vaccines Immunother12201623512356 31FettC.DeDiegoM.L.Regla-NavaJ.A.EnjuanesL.PerlmanS.Complete protection against severe" exact="acute" post="respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice"/>
  <result pre="with live virusHum Vaccines Immunother12201623512356 31FettC.DeDiegoM.L.Regla-NavaJ.A.EnjuanesL.PerlmanS.Complete protection against severe acute" exact="respiratory" post="syndrome coronavirus-mediated lethal respiratory disease in aged mice by"/>
  <result pre="live virusHum Vaccines Immunother12201623512356 31FettC.DeDiegoM.L.Regla-NavaJ.A.EnjuanesL.PerlmanS.Complete protection against severe acute respiratory" exact="syndrome" post="coronavirus-mediated lethal respiratory disease in aged mice by immunization"/>
  <result pre="Immunother12201623512356 31FettC.DeDiegoM.L.Regla-NavaJ.A.EnjuanesL.PerlmanS.Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal" exact="respiratory" post="disease in aged mice by immunization with a mouse-adapted"/>
  <result pre="31FettC.DeDiegoM.L.Regla-NavaJ.A.EnjuanesL.PerlmanS.Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory" exact="disease" post="in aged mice by immunization with a mouse-adapted virus"/>
  <result pre="virus lacking E proteinJÂ Virol8720136551655923576515 32LokugamageK.G.Yoshikawa-IwataN.ItoN.WattsD.M.WydeP.R.WangN.Chimeric coronavirus-like particles carrying severe" exact="acute" post="respiratory syndrome coronavirus (SCoV) S protein protect mice against"/>
  <result pre="lacking E proteinJÂ Virol8720136551655923576515 32LokugamageK.G.Yoshikawa-IwataN.ItoN.WattsD.M.WydeP.R.WangN.Chimeric coronavirus-like particles carrying severe acute" exact="respiratory" post="syndrome coronavirus (SCoV) S protein protect mice against challenge"/>
  <result pre="E proteinJÂ Virol8720136551655923576515 32LokugamageK.G.Yoshikawa-IwataN.ItoN.WattsD.M.WydeP.R.WangN.Chimeric coronavirus-like particles carrying severe acute respiratory" exact="syndrome" post="coronavirus (SCoV) S protein protect mice against challenge with"/>
  <result pre="S protein protect mice against challenge with SCoVVaccine26200879780818191004 33LiuY.V.MassareM.J.BarnardD.L.KortT.NathanM.WangL.Chimeric severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix"/>
  <result pre="protein protect mice against challenge with SCoVVaccine26200879780818191004 33LiuY.V.MassareM.J.BarnardD.L.KortT.NathanM.WangL.Chimeric severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1"/>
  <result pre="protect mice against challenge with SCoVVaccine26200879780818191004 33LiuY.V.MassareM.J.BarnardD.L.KortT.NathanM.WangL.Chimeric severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently"/>
  <result pre="mice against challenge with SARS-CoVVaccine2920116606661321762752 34VolzA.KupkeA.SongF.JanyS.FuxR.Shams-EldinH.Protective efficacy of recombinant modified" exact="vaccinia" post="virus Ankara delivering Middle East respiratory syndrome coronavirus spike"/>
  <result pre="efficacy of recombinant modified vaccinia virus Ankara delivering Middle East" exact="respiratory" post="syndrome coronavirus spike glycoproteinJÂ Virol8920158651865626018172 35MunsterV.J.WellsD.Protective efficacy of a"/>
  <result pre="of recombinant modified vaccinia virus Ankara delivering Middle East respiratory" exact="syndrome" post="coronavirus spike glycoproteinJÂ Virol8920158651865626018172 35MunsterV.J.WellsD.Protective efficacy of a novel"/>
  <result pre="novel human coronavirus hCoV-EMCJÂ Infect67201334835023685240 37ChiH.ZhengX.WangX.WangC.WangH.GaiW.DNA vaccine encoding Middle East" exact="respiratory" post="syndrome coronavirus S1 protein induces protective immune responses in"/>
  <result pre="human coronavirus hCoV-EMCJÂ Infect67201334835023685240 37ChiH.ZhengX.WangX.WangC.WangH.GaiW.DNA vaccine encoding Middle East respiratory" exact="syndrome" post="coronavirus S1 protein induces protective immune responses in miceVaccine3520172069207528314561"/>
  <result pre="I clinical trialVaccine2620086338634318824060 39ModjarradK.RobertsC.C.MillsK.T.CastellanoA.R.PaolinoK.MuthumaniK.Safety and immunogenicity of an anti-Middle East" exact="respiratory" post="syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm,"/>
  <result pre="clinical trialVaccine2620086338634318824060 39ModjarradK.RobertsC.C.MillsK.T.CastellanoA.R.PaolinoK.MuthumaniK.Safety and immunogenicity of an anti-Middle East respiratory" exact="syndrome" post="coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation"/>
  <result pre="glycoproteins reveal the dynamic receptor binding domainsNat Commun820171509228393837 42DuL.JiangS.Middle East" exact="respiratory" post="syndrome: current status and future prospects for vaccine developmentExpet"/>
  <result pre="of the 2019 novel human-pathogenic coronavirus isolated from patients with" exact="acute" post="respiratory disease in Wuhan, Hubei, ChinaEmerg Microb Infect92020[???-???] 44JiangS.DuL.ShiZ.An"/>
  <result pre="the 2019 novel human-pathogenic coronavirus isolated from patients with acute" exact="respiratory" post="disease in Wuhan, Hubei, ChinaEmerg Microb Infect92020[???-???] 44JiangS.DuL.ShiZ.An emerging"/>
  <result pre="2019 novel human-pathogenic coronavirus isolated from patients with acute respiratory" exact="disease" post="in Wuhan, Hubei, ChinaEmerg Microb Infect92020[???-???] 44JiangS.DuL.ShiZ.An emerging coronavirus"/>
  <result pre="in Wuhan, Hubei, ChinaEmerg Microb Infect92020[???-???] 44JiangS.DuL.ShiZ.An emerging coronavirus causing" exact="pneumonia" post="outbreak in Wuhan, China: calling for developing therapeutic and"/>
  <result pre="monoclonal antibodies targeting multiple antigenic sites on the Middle East" exact="respiratory" post="syndrome coronavirus spike glycoprotein to avoid neutralization escapeJÂ Virol922018e02002e0201729514901"/>
  <result pre="antibodies targeting multiple antigenic sites on the Middle East respiratory" exact="syndrome" post="coronavirus spike glycoprotein to avoid neutralization escapeJÂ Virol922018e02002e0201729514901 46OlsenC.W.AÂ"/>
  <result pre="glycoprotein to avoid neutralization escapeJÂ Virol922018e02002e0201729514901 46OlsenC.W.AÂ review of feline" exact="infectious" post="peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccinationVet"/>
  <result pre="to avoid neutralization escapeJÂ Virol922018e02002e0201729514901 46OlsenC.W.AÂ review of feline infectious" exact="peritonitis" post="virus: molecular biology, immunopathogenesis, clinical aspects, and vaccinationVet Microbiol3619931378236772"/>
  <result pre="and virus entryBiochem Biophys Res Commun325200444545215530413 50HeY.LuH.SiddiquiP.ZhouY.JiangS.Receptor-binding domain of severe" exact="acute" post="respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes"/>
  <result pre="virus entryBiochem Biophys Res Commun325200444545215530413 50HeY.LuH.SiddiquiP.ZhouY.JiangS.Receptor-binding domain of severe acute" exact="respiratory" post="syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that"/>
  <result pre="entryBiochem Biophys Res Commun325200444545215530413 50HeY.LuH.SiddiquiP.ZhouY.JiangS.Receptor-binding domain of severe acute respiratory" exact="syndrome" post="coronavirus spike protein contains multiple conformation-dependent epitopes that induce"/>
  <result pre="antibodiesJÂ Immunol17420054908491515814718 51HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.Identification of a critical neutralization determinant of severe" exact="acute" post="respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccinesVirology3342005748215749124"/>
  <result pre="Immunol17420054908491515814718 51HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.Identification of a critical neutralization determinant of severe acute" exact="respiratory" post="syndrome (SARS)-associated coronavirus: importance for designing SARS vaccinesVirology3342005748215749124 52HeY.LiJ.LiW.LustigmanS.FarzanM.JiangS.Cross-neutralization"/>
  <result pre="51HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.Identification of a critical neutralization determinant of severe acute respiratory" exact="syndrome" post="(SARS)-associated coronavirus: importance for designing SARS vaccinesVirology3342005748215749124 52HeY.LiJ.LiW.LustigmanS.FarzanM.JiangS.Cross-neutralization of"/>
  <result pre="designing SARS vaccinesVirology3342005748215749124 52HeY.LiJ.LiW.LustigmanS.FarzanM.JiangS.Cross-neutralization of human and palm civet severe" exact="acute" post="respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain"/>
  <result pre="SARS vaccinesVirology3342005748215749124 52HeY.LiJ.LiW.LustigmanS.FarzanM.JiangS.Cross-neutralization of human and palm civet severe acute" exact="respiratory" post="syndrome coronaviruses by antibodies targeting the receptor-binding domain of"/>
  <result pre="vaccinesVirology3342005748215749124 52HeY.LiJ.LiW.LustigmanS.FarzanM.JiangS.Cross-neutralization of human and palm civet severe acute respiratory" exact="syndrome" post="coronaviruses by antibodies targeting the receptor-binding domain of spike"/>
  <result pre="Immunother102014648658 55http://www.smetimes.in/smetimes/news/global-business/2020/Jan/23/china-us-vaccine50374.html. 56MehandM.S.Al-ShorbajiF.MillettP.MurgueB.The WHO R&amp;amp;D Blueprint: 2018 review of emerging" exact="infectious diseases" post="requiring urgent research and development effortsAntivir Res1592018636730261226 57DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East"/>
  <result pre="diseases requiring urgent research and development effortsAntivir Res1592018636730261226 57DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East" exact="respiratory" post="syndrome and severe acute respiratory syndrome: current therapeutic options"/>
  <result pre="requiring urgent research and development effortsAntivir Res1592018636730261226 57DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East respiratory" exact="syndrome" post="and severe acute respiratory syndrome: current therapeutic options and"/>
  <result pre="and development effortsAntivir Res1592018636730261226 57DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East respiratory syndrome and severe" exact="acute" post="respiratory syndrome: current therapeutic options and potential targets for"/>
  <result pre="development effortsAntivir Res1592018636730261226 57DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East respiratory syndrome and severe acute" exact="respiratory" post="syndrome: current therapeutic options and potential targets for novel"/>
  <result pre="and identification of fusion inhibitorsLancet363200493894715043961 60LuL.LiuQ.ZhuY.ChanK.H.QinL.LiY.Structure-based discovery of Middle East" exact="respiratory" post="syndrome coronavirus fusion inhibitorNat Commun52014306724473083 61XiaS.YanL.AÂ pan-coronavirus fusion inhibitor"/>
  <result pre="identification of fusion inhibitorsLancet363200493894715043961 60LuL.LiuQ.ZhuY.ChanK.H.QinL.LiY.Structure-based discovery of Middle East respiratory" exact="syndrome" post="coronavirus fusion inhibitorNat Commun52014306724473083 61XiaS.YanL.AÂ pan-coronavirus fusion inhibitor targeting"/>
  <result pre="coronavirus spikeSci Adv52019eaav458030989115 62BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of the structural proteins of severe" exact="acute" post="respiratory syndrome coronavirus to protective immunityProc Natl Acad Sci"/>
  <result pre="spikeSci Adv52019eaav458030989115 62BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of the structural proteins of severe acute" exact="respiratory" post="syndrome coronavirus to protective immunityProc Natl Acad Sci U"/>
  <result pre="Adv52019eaav458030989115 62BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of the structural proteins of severe acute respiratory" exact="syndrome" post="coronavirus to protective immunityProc Natl Acad Sci U S"/>
  <result pre="A10120049804980915210961 63OlsenC.W.CorapiW.V.JacobsonR.H.SimkinsR.A.SaifL.J.ScottF.W.Identification of antigenic sites mediating antibody-dependent enhancement of feline" exact="infectious" post="peritonitis virus infectivityJÂ Gen Virol74Pt 419937457497682252 64BakkerA.B.MarissenW.E.KramerR.A.RiceA.B.WeldonW.C.NiezgodaM.Novel human monoclonal"/>
  <result pre="63OlsenC.W.CorapiW.V.JacobsonR.H.SimkinsR.A.SaifL.J.ScottF.W.Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious" exact="peritonitis" post="virus infectivityJÂ Gen Virol74Pt 419937457497682252 64BakkerA.B.MarissenW.E.KramerR.A.RiceA.B.WeldonW.C.NiezgodaM.Novel human monoclonal antibody"/>
  <result pre="Virol74Pt 419937457497682252 64BakkerA.B.MarissenW.E.KramerR.A.RiceA.B.WeldonW.C.NiezgodaM.Novel human monoclonal antibody combination effectively neutralizing natural" exact="rabies" post="virus variants and individual inÂ vitro escape mutantsJÂ Virol7920059062906815994800"/>
  <result pre="of a human transgenic mouse model from lethal Middle East" exact="respiratory" post="syndrome (MERS)-coronavirus infectionAntivir Res132201614114827312105 66PascalK.E.ColemanC.M.MujicaA.O.KamatV.BaditheA.FairhurstJ.Pre- and postexposure efficacy of"/>
  <result pre="a human transgenic mouse model from lethal Middle East respiratory" exact="syndrome" post="(MERS)-coronavirus infectionAntivir Res132201614114827312105 66PascalK.E.ColemanC.M.MujicaA.O.KamatV.BaditheA.FairhurstJ.Pre- and postexposure efficacy of fully"/>
  <result pre="S A1122015104731047826216974 69ChenZ.BaoL.ChenC.ZouT.XueY.LiF.Human neutralizing monoclonal antibody inhibition of Middle East" exact="respiratory" post="syndrome coronavirus replication in the common MarmosetJÂ Infect Dis21520171807181528472421"/>
  <result pre="A1122015104731047826216974 69ChenZ.BaoL.ChenC.ZouT.XueY.LiF.Human neutralizing monoclonal antibody inhibition of Middle East respiratory" exact="syndrome" post="coronavirus replication in the common MarmosetJÂ Infect Dis21520171807181528472421 70XuJ.JiaW.WangP.ZhangS.ShiX.WangX.Antibodies"/>
  <result pre="common MarmosetJÂ Infect Dis21520171807181528472421 70XuJ.JiaW.WangP.ZhangS.ShiX.WangX.Antibodies and vaccines against Middle East" exact="respiratory" post="syndrome coronavirusEmerg Microb Infect82019841856 71CoughlinM.M.PrabhakarB.S.Neutralizing human monoclonal antibodies to"/>
  <result pre="MarmosetJÂ Infect Dis21520171807181528472421 70XuJ.JiaW.WangP.ZhangS.ShiX.WangX.Antibodies and vaccines against Middle East respiratory" exact="syndrome" post="coronavirusEmerg Microb Infect82019841856 71CoughlinM.M.PrabhakarB.S.Neutralizing human monoclonal antibodies to severe"/>
  <result pre="syndrome coronavirusEmerg Microb Infect82019841856 71CoughlinM.M.PrabhakarB.S.Neutralizing human monoclonal antibodies to severe" exact="acute" post="respiratory syndrome coronavirus: target, mechanism of action, and therapeutic"/>
  <result pre="coronavirusEmerg Microb Infect82019841856 71CoughlinM.M.PrabhakarB.S.Neutralizing human monoclonal antibodies to severe acute" exact="respiratory" post="syndrome coronavirus: target, mechanism of action, and therapeutic potentialRev"/>
  <result pre="Microb Infect82019841856 71CoughlinM.M.PrabhakarB.S.Neutralizing human monoclonal antibodies to severe acute respiratory" exact="syndrome" post="coronavirus: target, mechanism of action, and therapeutic potentialRev Med"/>
  <result pre="pathwayPLoS Pathog42008e100019718989460 74OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.Ribavirin and interferon alfa-2a for severe Middle East" exact="respiratory" post="syndrome coronavirus infection: a retrospective cohort studyLancet Infect Dis1420141090109525278221"/>
  <result pre="Pathog42008e100019718989460 74OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.Ribavirin and interferon alfa-2a for severe Middle East respiratory" exact="syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect Dis1420141090109525278221 75SheahanT.P.SimsA.C.Broad-spectrum"/>
  <result pre="coronavirusesSci Transl Med92017eaal3653 76GrossA.E.BrysonM.L.Oral ribavirin for the treatment of noninfluenza" exact="respiratory" post="viral infections: a systematic reviewAnn Pharmacother4920151125113526228937 77ChuC.M.ChengV.C.HungI.F.WongM.M.ChanK.H.ChanK.S.Role of lopinavir/ritonavir"/>
  <result pre="Transl Med92017eaal3653 76GrossA.E.BrysonM.L.Oral ribavirin for the treatment of noninfluenza respiratory" exact="viral" post="infections: a systematic reviewAnn Pharmacother4920151125113526228937 77ChuC.M.ChengV.C.HungI.F.WongM.M.ChanK.H.ChanK.S.Role of lopinavir/ritonavir in"/>
  <result pre="and clinical findingsThorax59200425225614985565 78ChanJ.F.ChanK.H.KaoR.Y.ToK.K.ZhengB.J.LiC.P.Broad-spectrum antivirals for the emerging Middle East" exact="respiratory" post="syndrome coronavirusJÂ Infect67201360661624096239 79LoutfyM.R.BlattL.M.SiminovitchK.A.WardS.WolffB.LhoH.Interferon alfacon-1 plus corticosteroids in severe"/>
  <result pre="clinical findingsThorax59200425225614985565 78ChanJ.F.ChanK.H.KaoR.Y.ToK.K.ZhengB.J.LiC.P.Broad-spectrum antivirals for the emerging Middle East respiratory" exact="syndrome" post="coronavirusJÂ Infect67201360661624096239 79LoutfyM.R.BlattL.M.SiminovitchK.A.WardS.WolffB.LhoH.Interferon alfacon-1 plus corticosteroids in severe acute"/>
  <result pre="respiratory syndrome coronavirusJÂ Infect67201360661624096239 79LoutfyM.R.BlattL.M.SiminovitchK.A.WardS.WolffB.LhoH.Interferon alfacon-1 plus corticosteroids in severe" exact="acute" post="respiratory syndrome: a preliminary studyJAMA29020033222322814693875 80BelshawR.GardnerA.RambautA.PybusO.G.Pacing a small cage:"/>
  <result pre="syndrome coronavirusJÂ Infect67201360661624096239 79LoutfyM.R.BlattL.M.SiminovitchK.A.WardS.WolffB.LhoH.Interferon alfacon-1 plus corticosteroids in severe acute" exact="respiratory" post="syndrome: a preliminary studyJAMA29020033222322814693875 80BelshawR.GardnerA.RambautA.PybusO.G.Pacing a small cage: mutation"/>
 </snippets>
</snippetsTree>
